Jeff A Miller

Jeff Miller serves as the Program Point of Contact for the Centers for Disease Control and Prevention, playing a critical role in aligning procurement activities with the agency’s public health mission. He facilitates the acquisition of scientific, diagnostic, and pharmaceutical resources essential to disease surveillance, laboratory capacity building, and emergency response initiatives. Working closely with scientific and operational teams, Miller ensures that contracting strategies support the deployment of advanced analytical tools, vaccine distribution systems, and laboratory diagnostics. His responsibilities include defining technical requirements, evaluating vendor capabilities, and coordinating with contracting officers to execute complex, mission-critical procurements under federal acquisition regulations. Miller maintains sustained relationships with leading pharmaceutical and medical supply contractors, including Merck Sharp & Dohme LLC, GlaxoSmithKline LLC, Pfizer Inc., Sanofi Pasteur Inc., and McKesson Specialty Distribution LLC. These partnerships are primarily centered on the procurement of vaccines, therapeutic agents, cold-chain logistics, and specialized medical distribution services. His engagement with these vendors reflects a focus on high-reliability supply chains and regulatory-compliant manufacturing, ensuring timely access to mission-critical public health products during outbreaks and routine immunization programs. Miller’s contracting portfolio reflects a strong preference for open competition, with 92.4% of acquisitions issued without set-aside designations. While small business participation is limited, the 7.6% allocated to Total Small Business Set-Asides demonstrates a measured commitment to socioeconomic goals, particularly where technical expertise or scalable capacity is required. His approach prioritizes mission readiness over socioeconomic quotas, ensuring that procurement decisions are driven by scientific and operational necessity. His primary procurement focus lies in NAICS 334516 (analytical laboratory instrument manufacturing) and 541690 (scientific consulting services), with significant activity in pharmaceutical preparation (325412) and medical laboratory services (621511). This reflects deep expertise in procuring diagnostic equipment, laboratory reagents, bioinformatics tools, and technical advisory services essential to CDC’s core functions in outbreak response and public health surveillance.